E-LIB Suche - Ergebnisse für: Shukui Qin

1

A Phase 3 Study of Pembrolizumab Versus Placebo for Previou..:

Shukui Qin ; Weijia Fang ; Zhenggang Ren...
https://beta.karger.com/Article/FullText/535338. , 2024

Link: https://doi.org/10.1159/..

2

Guidelines for the Diagnosis and Treatment of Primary Liver..:

Jian Zhou ; Huichuan Sun ; Zheng Wang...
https://www.karger.com/Article/FullText/530495. , 2023

Link: https://doi.org/10.1159/..

3

Chinese expert consensus recommendations for the administra..:

Jun Wang ; Bicheng Zhang ; Ling Peng...
https://doi.org/10.1177/17588359231187205. , 2023

Link: https://doi.org/10.1177/..

4

PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequenti..:

Ghassan K. Abou-Alfa ; Peter R. Galle ; Yee Chao...
https://beta.karger.com/Article/FullText/533650. , 2023

Link: https://doi.org/10.1159/..

5

Safety and efficacy of apatinib in patients with advanced g..:

Jin Li ; Shukui Qin ; Lu Wen...
https://doi.org/10.1186/s12916-023-02841-7. , 2023

Link: https://doi.org/10.1186/..

6

A novel AKR1C3 specific prodrug AST-3424 and its combinatio..:

Chen Xun ; Yu Zhang ; Xia Zheng.
http://www.sciencedirect.com/science/article/pii/S134786132300018X. , 2023

Link: https://doi.org/10.1016/..

7

Central nervous system efficacy of furmonertinib (AST2818) ..:

Xingsheng Hu ; Shucai Zhang ; Zhiyong Ma...
https://doi.org/10.1186/s12916-023-02865-z. , 2023

Link: https://doi.org/10.1186/..

8

Table_1_A multi-center effectiveness comparison study of fr..:

Ying Jin ; Jin Li ; Lin Shen...
doi:10.3389/fonc.2022.1044328.s001. , 2022

Link: https://doi.org/10.3389/..

9

The In-Vitro Antitumor Effects of AST-3424 Monotherapy and ..:

Yu Zhang ; Shukui Qin ; Jiaojiao Chao...
https://www.frontiersin.org/articles/10.3389/fonc.2022.885139/full. , 2022

Link: https://doi.org/10.3389/..

10

DataSheet_1_The In-Vitro Antitumor Effects of AST-3424 Mono..:

Yu Zhang ; Shukui Qin ; Jiaojiao Chao...
doi:10.3389/fonc.2022.885139.s001. , 2022

Link: https://doi.org/10.3389/..

11

Chinese Society of Clinical Oncology (CSCO): Clinical guide..:

Jiujie Cui ; Feng Jiao ; Qi Li...
http://www.sciencedirect.com/science/article/pii/S2667005422000618. , 2022

Link: https://doi.org/10.1016/..

12

Systemic therapy for hepatocellular carcinoma: Chinese cons..:

Yongkun Sun ; Wen Zhang ; Xinyu Bi...
https://www.karger.com/Article/FullText/521596. , 2022

Link: https://doi.org/10.1159/..

13

A multi-center effectiveness comparison study of fruquintin..:

Ying Jin ; Jin Li ; Lin Shen...
https://www.frontiersin.org/articles/10.3389/fonc.2022.1044328/full. , 2022

Link: https://doi.org/10.3389/..

14

Ramucirumab as second-line treatment in Chinese patients wi..:

Guoliang Shao ; Yuxian Bai ; Xianglin Yuan...
http://www.sciencedirect.com/science/article/pii/S2589537022004096. , 2022

Link: https://doi.org/10.1016/..

15

Hepatic Events and Viral Kinetics in Hepatocellular Carcino..:

Chiun Hsu ; Michel Ducreux ; Andrew X. Zhu...
https://www.karger.com/Article/FullText/525499. , 2022

Link: https://doi.org/10.1159/..